NextPlat Corp (NASDAQ: NXPL) has restored compliance with Nasdaq’s minimum bid‑price requirement of $1.00 per share, ensuring the company remains listed on the Nasdaq Capital Market. The company received a compliance letter confirming that its closing bid price stayed at or above the threshold for ten consecutive business days from April 13 to April 24, 2026.
The compliance period began immediately after a one‑for‑ten reverse stock split that took effect on April 13, 2026. The split lifted the share price above the $1.00 floor, allowing the company to meet the listing rule and avoid the risk of delisting. Nasdaq confirmed the compliance on April 27, 2026, the same day the company reported the achievement.
NextPlat’s financial backdrop includes an 18% decline in total revenue to $54.3 million for the year ended December 31, 2025, driven largely by a $12.6 million drop in healthcare operations revenue to $39.7 million. The decline reflects fewer prescriptions filled and a reduction in 340B contract revenue. In contrast, e‑commerce revenue grew to $14.6 million from $13.8 million, a modest increase that partially offsets the healthcare shortfall. Operating expenses fell 50% to $19.9 million, a result of aggressive cost‑cutting measures that have helped the company reduce its net loss to $11.7 million, or $0.44 per diluted share.
CEO David Phipps highlighted the company’s turnaround strategy, noting that the “closing of 2025 marks the start of an exciting new period” as cost‑cutting and operational improvements begin to lift performance. He added that the company is “positioned to significantly grow the business” in the first half of 2026 through investments in healthcare operations, business development, and customer service, signaling confidence in a path to profitability.
Market reaction to the compliance announcement was positive. As of April 27, 2026, the stock trades at $6.67, reflecting a nearly 14% return over the past week. The share price had moved 7.06% prior to the compliance announcement, indicating that investors viewed the event as a relief from the delisting risk and a sign of improved financial discipline.
The compliance achievement underscores NextPlat’s ability to navigate regulatory hurdles while executing a dual‑business strategy. The reverse split and subsequent price stabilization demonstrate the company’s willingness to take decisive actions to maintain listing status. Coupled with cost reductions and a shift toward higher‑margin e‑commerce revenue, the company is positioning itself for a potential rebound in profitability, though it remains under pressure from declining healthcare revenue and ongoing losses.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.